Experimental mesothelioma treatment being developed in Germany
Mesothelioma, an aggressive, asbestos-related cancer that can attack the membranes surrounding the heart, lungs or abdomen, is generally difficult to treat. A doctor in Frankfurt is exploring the use of chemoembolization to treat mesothelioma, and anecdotally, the treatment has shown some promise.
Dr. Thomas Vogl has studied the use of chemoembolization to treat tumors in the liver, and has demonstrated that the procedure, while minimally invasive, can be helpful to patients.
More study is needed to determine what the benefits will be for mesothelioma patients, but given this cancer’s resistance to current treatments, the development of new treatment options is vital. There is interest in conducting clinical trials on the treatment in the UK and elsewhere.
For the full story, go to Rochdale Online.
